Pharmaceutical - Mergers & Acquisitions

Filter

Current filters:

Mergers & Acquisitions

Popular Filters

101 to 125 of 661 results

BioAlliance Pharma and Topotarget merge to create leader in orphan oncology diseases

BioAlliance Pharma and Topotarget merge to create leader in orphan oncology diseases

16-04-2014

French orphan drug developer BioAlliance Pharma and Denmark’s Topotarget today announced their intention…

belinostatBioAlliance PharmaLivatagMergers & AcquisitionsOncologyPharmaceuticalRare diseasesTopotarget

Mallinckrodt to acquire Questcor Pharma for around $5.6 billion

Mallinckrodt to acquire Questcor Pharma for around $5.6 billion

07-04-2014

In a second M&A deal so far this year, Ireland-headquartered Mallinckrodt says it has entered a definitive…

ActharBusinessBusiness FinanceCorporate financeMallinckrodtMergers & AcquisitionsPharmaceuticalPharmaceuticalsQuestcor PharmaStock market

Aqua’s acquisition to push Almirall in US dermatology market

03-04-2014

Spain’s largest drugmaker, Almirall (ALM: MC), announced at the end of last year the acquisition of…

AlmirallAqua PharmaceuticalsDermatologicalsMergers & AcquisitionsPharmaceutical

Johnson & Johnson accepts $4 billion offer for Ortho-Clinical Diagnostics

Johnson & Johnson accepts $4 billion offer for Ortho-Clinical Diagnostics

01-04-2014

US health care giant Johnson & Johnson revealed yesterday that it has accepted the binding offer from…

Johnson & JohnsonMergers & AcquisitionsPharmaceutical

Lansen Pharma acquires China rights to Novartis’ Sicorten Plus

Lansen Pharma acquires China rights to Novartis’ Sicorten Plus

31-03-2014

Hong Kong-listed Lansen Pharmaceutical has acquired the pharmaceutical product, marketed and sold in…

Asia-PacificChinaDermatologicalsLansen PharmaceuticalMergers & AcquisitionsNovartisPharmaceuticalSicorten

GSK acquires remaining 30% of its Indonesian Consumer Healthcare business

GSK acquires remaining 30% of its Indonesian Consumer Healthcare business

28-03-2014

US pharma giant GlaxoSmithKline has acquired full ownership of its Indonesian Consumer Healthcare business…

Asia-PacificGlaxoSmithKlineIndonesiaMergers & AcquisitionsPharmaceuticalProduction

Baxter to split, creating two separate health care companies

Baxter to split, creating two separate health care companies

28-03-2014

News that USA-based Baxter International plans to create two separate, independent global health care…

Baxter InternationalManagementMergers & AcquisitionsPharmaceutical

India’s Lupin acquires Laboratorios Grin to enter Latin American market

27-03-2014

Indian pharma major Lupin has acquired a 100% equity stake in Mexican company Laboratorios Grin, subject…

IndiaLaboratorios GrinLupinMergers & AcquisitionsMexicoOphthalmicsPharmaceutical

AstraZeneca acquires full control of Japanese subsidiary

AstraZeneca acquires full control of Japanese subsidiary

26-03-2014

Anglo-Swedish drug major AstraZeneca today announced the completion of the purchase of Sumitomo Chemical’s…

Asia-PacificAstraZenecaJapanMergers & AcquisitionsPharmaceutical

Horizon Pharma in reverse merger to acquire Vidara for ~$660 million

Horizon Pharma in reverse merger to acquire Vidara for ~$660 million

20-03-2014

USA-based Horizon Pharma and privately-held, Ireland-based, Vidara Therapeutics International have entered…

Horizon PharmaMergers & AcquisitionsPharmaceuticalVidara Therapeutics International

Five Prime rockets on immuno-oncology deal with Bristol-Myers Squibb

Five Prime rockets on immuno-oncology deal with Bristol-Myers Squibb

17-03-2014

Shares of Five Prime Therapeutics leapt 15% to $21.48 in early trading, after the company said it has…

Bristol-Myers SquibbFive Prime TherapeuticsLicensingMergers & AcquisitionsOncologyPharmaceutical

Vectura to buy Germany’s Activaero for 130 million euros

Vectura to buy Germany’s Activaero for 130 million euros

14-03-2014

UK developer of inhaled therapies Vectura says it is acquiring privately-held German company Activaero…

ActivaeroFinancialMergers & AcquisitionsPharmaceuticalRespiratory and PulmonaryVectura

UK cancer drug companies combine expertise in merger

UK cancer drug companies combine expertise in merger

13-03-2014

UK oncology company Incanthera says it has acquired Onco-NX, the University of Salford drug discovery…

IncantheraMergers & AcquisitionsOnco-NXOncologyPharmaceutical

Sustainability of sky-high M&A valuations will be the biggest question for 2014, says new report

12-03-2014

The cautious optimism of 2012 turned into a fully fledged biotech boom in 2013, marked by surging company…

BiotechnologyGlobalMergers & AcquisitionsPharmaceutical

Are you overlooking the “X Factor” in Biopharma M&A? asks JLL expert

Are you overlooking the “X Factor” in Biopharma M&A? asks JLL expert

12-03-2014

When Merck & Co acquired Schering-Plough in 2009, the corporate real estate team reduced the combined…

ManagementMerck & CoMergers & AcquisitionsPharmaceutical

GSK increases stake in Indian Pharma subsidiary to 75%

GSK increases stake in Indian Pharma subsidiary to 75%

10-03-2014

UK pharma giant GlaxoSmithKline says that, following the voluntary open offer undertaken by its Indian…

Asia-PacificGlaxoSmithKlineIndiaMergers & AcquisitionsPharmaceutical

Debiopharm to acquire products or companies to expand activities at Swiss manufacturing facility

06-03-2014

Swiss independent drug developer Debiopharm say it plans to expand and optimize activities at Debiopharm…

DebiopharmMergers & AcquisitionsPharmaceuticalProduction

France’s AAA makes acquisition, gains orphan status for Gallium-68 DOTATATE

04-03-2014

French molecular nuclear medicines specialist Advanced Accelerator Applications SA (AAA) has acquired…

Advanced Accelerator ApplicationsGallium-68 DOTATATEMergers & AcquisitionsPharmaceuticalRegulation

Perrigo transfers ELND005 assets; buys OTC products

01-03-2014

Drugmaker Perrigo has entered into a series of agreements with existing collaboration partner, Transition…

ELND005Mergers & AcquisitionsNeurologicalPerrigoPharmaceuticalResearchTransition Therapeutics

Bayer to buy Chinese OTC/TCM drugmaker Dihon Pharma

27-02-2014

Germany’s leading pharma firm Bayer says it plans to acquire 100% of Dihon Pharmaceutical, a privately…

BayerDihon PharmaceuticalMergers & AcquisitionsPharmaceutical

Way clear for Bayer to complete Algeta acquisition

26-02-2014

The way is now clear for Germany’s Bayer to acquire Norwegian pharmaceutical company Algeta, under…

AlgetaBayerMergers & AcquisitionsOncologyPharmaceuticalXofigo

Indian drugmakers readying for next “Patent cliff”

24-02-2014

The strategic drug reviews, as well as mergers and acquisitions – such as Actavis buying out Forest…

Asia-PacificGenericsIndiaMergers & AcquisitionsPatentsPharmaceuticalRegulation

Fitch affirms Actavis at “BBB-” on Forest Labs acquisition; outlook Stable

20-02-2014

Fitch Ratings has affirmed the ratings of generic drugs major Actavis and subsidiaries at “BBB-”…

ActavisFinancialForest LaboratoriesMergers & AcquisitionsPharmaceutical

101 to 125 of 661 results

Back to top